Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Deals
Biotech
Concentra swoops in to purchase struggling Kronos
With the walls quickly closing in, Kronos Bio has accepted a buyout from notorious biotech acquirer Concentra Biosciences.
Gabrielle Masson
May 1, 2025 3:07pm
Amicus pays Dimerix $30M for late-phase rare kidney disease drug
May 1, 2025 10:59am
Investor pressures Acelyrin to exit Alumis merger and liquidate
Apr 30, 2025 10:30am
Novartis pays $800M to buy Regulus for phase 3-ready kidney drug
Apr 30, 2025 9:30am
Ferrer nabs European rights for ALS asset in €500M pact
Apr 28, 2025 2:40pm
M&A remains ‘top priority’ for pharmas in face of tariff threat
Apr 25, 2025 10:41am